In this study, we have characterized 25 GCK variants identified through diagnostic testing (n = 5) or through exome sequencing studies in type 2 diabetes cases and controls (n = 20) using a suite of low-throughput in vitro assays that assess enzyme activity, stability, and regulation by pharmacological activators and physiological inhibitors. Here, GCK is linked to type 2 diabetes mellitus.